Pasithea Therapeutics Corp
(KTTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,968 | 12,009 | 16,331 | 19,585 | 26,648 |
| Other current assets | 105 | 145 | 145 | 202 | 575 |
| TOTAL | $8,643 | $13,193 | $16,692 | $20,771 | $28,037 |
| Non-Current Assets | |||||
| PPE Net | 132 | 137 | 141 | 146 | 173 |
| Intangibles | 8,889 | 9,047 | 9,204 | 9,362 | 9,519 |
| Other Non-Current Assets | 0 | 32 | 79 | 378 | 420 |
| TOTAL | $9,021 | $9,215 | $9,425 | $9,886 | $10,113 |
| Total Assets | $17,663 | $22,408 | $26,117 | $30,657 | $38,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,395 | 2,434 | 2,552 | 1,870 | 1,926 |
| TOTAL | $1,395 | $2,467 | $2,634 | $2,044 | $2,229 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 93 | 58 | 84 | 240 | 330 |
| TOTAL | $93 | $58 | $84 | $240 | $330 |
| Total Liabilities | $1,488 | $2,525 | $2,718 | $2,284 | $2,559 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,044 | 1,043 | 1,042 | 1,042 | 1,307 |
| Common Shares | 0 | 0 | 0 | 18 | 18 |
| Retained earnings | -43,046 | -39,179 | -35,319 | -30,270 | -26,658 |
| Other shareholders' equity | -8 | -5 | -5 | -8 | -4 |
| TOTAL | $16,175 | $19,884 | $23,399 | $28,374 | $35,590 |
| Total Liabilities And Equity | $17,663 | $22,408 | $26,117 | $30,657 | $38,149 |